Antheia (Series C)

Funding Details
Awarder
Inbox
Date Award
June 03, 2025
Vertical
Biotechnology
Funding URL
View Funding Page
Funding Amount:
$56,000,000

Company Info
Traction
Antheia has successfully raised $56 million in Series C funding to support its global commercialization strategy.
Company Description
Antheia is a biotechnology company focused on the development of sustainable and scalable methods for producing plant-based pharmaceuticals.
Market
Pharmaceuticals
Location
USA

Links